Diastolic Dysfunction Using Artificial Intelligence Applied to a Single Handheld Ultrasound Image

Overview

About this study

The aim of this study is to prospectively validate the novel AI based model in patients undergoing clinically indicated transthoracic echocardiography using a four-chamber view acquired with a hand-held point of care ultrasound.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adult male and female, age from 18 years old.
Having signs and symptoms of HFpEF. HFpEF (EF ≥ 40%, PCWP at rest ≥15 mm Hg).
With 1, 2, 3 grades or indeterminate degree of DD (ACC/AHA stages C and D HF).

Exclusion Criteria:

Reduced Ejection Fraction (EF ≤ 39%), mitral valve prosthesis, mitral stenosis.

Eligibility last updated 9/16/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Patricia Pellikka, M.D.	Open for enrollment	Contact information: Halley Davison MBA/HCM (507) 422-6246 davison.halley@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Patricia Pellikka, M.D.

Open for enrollment

Contact information:

Halley Davison MBA/HCM

(507) 422-6246

davison.halley@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials